Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.
P/E ratio for Semler Scientific, Inc. (SMLR)
P/E ratio as of 2023: 14.49
According to Semler Scientific, Inc.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 14.49. At the end of 2022 the company had a P/E ratio of 15.50.
P/E ratio history for Semler Scientific, Inc. from 2011 to 2023
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2023 | 14.49 |
| 2022 | 15.50 |
| 2021 | 35.82 |
| 2020 | 44.19 |
| 2019 | 20.50 |
| 2018 | 52.12 |
| 2017 | -28.57 |
| 2016 | -2.91 |
| 2015 | -1.48 |
| 2014 | -1.78 |
| 2013 | -14.74 |
| 2012 | -7.14 |
| 2011 | -10.43 |